| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |